Compositions and Methods for the Treatment of Presbyopia (2014)
Lenz Therapeutics Operations, Inc.
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 14 of these applications claim priority to application 61/938,438, filed Feb 11, 2014. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,089,562 | Compositions and Methods for the Treatment of Presbyopia In force · High confidence UsedRemaining | Lenz Therapeutics Operations, Inc. | In force | High confidence | ||
| US 9,314,427 | Compositions and Methods for the Improvement of Distance Vision and the Treatment of Refractive Errors of the Eye In force · High confidence | Lenz Therapeutics Operations, Inc. | In force | High confidence | ||
| US 9,320,709 | Storage Stable Compositions and Methods for the Treatment of Refractive Errors of the Eye In force · High confidence | Lenz Therapeutics Operations, Inc. | In force | High confidence | ||
| US 9,833,441 | Compositions and Methods for the Treatment of Presbyopia In force · High confidence | Lenz Therapeutics Operations, Inc. | In force | High confidence | ||
| US 9,844,537 | Compositions and Methods for the Treatment of Presbyopia In force · High confidence | Lenz Therapeutics Operations, Inc. | In force | High confidence | ||
| US 9,968,594 | Compositions and Methods for the Treatment of Presbyopia In force · High confidence | Lenz Therapeutics Operations, Inc. | In force | High confidence | ||
| US 10,052,313 | Compositions and Methods for the Treatment of Presbyopia In force · High confidence | Lenz Therapeutics Operations, Inc. | In force | High confidence | ||
| US 10,064,818 | Compositions and Methods for the Treatment of Presbyopia In force · High confidence | Lenz Therapeutics Operations, Inc. | In force | High confidence | ||
| US 10,307,408 | Contact Lens Compositions and Methods for the Treatment of Presbyopia In force · High confidence | Lenz Therapeutics Operations, Inc. | In force | High confidence | ||
| US 10,617,763 | Compositions and Methods for the Treatment of Presbyopia In force · High confidence | Lenz Therapeutics Operations, Inc. | In force | High confidence | ||
| 20 more records in this group · Pro | ||||||
10 of 30 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 30.
15 of these are in force and held by Lenz Therapeutics Operations, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.